Notice Type
Departmental
Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Hepatitis A inactivated 720 EU in 0.5 mL Injection, vial SmithKline Beecham Biologicals, Rixensart, Belgium Havrix Junior Vaccine Hepatitis A inactivated 720 EU in 0.5 mL Injection, pre-filled syringe SmithKline Beecham Biologicals, Rixensart, Belgium Havrix Junior Vaccine Cilazapril 0.5 mg, 1 mg, 2.5 mg, 5 mg Tablets F Hoffmann-La Roche Limited, Basle, Switzerland Inhibace Pravastatin sodium 40 mg Tablet Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia Lipostat Human Immunoglobulin G 320 mg in 2 mL, 800 mg in 5 mL (i.e. 16% w/v solution of IgG) Injection, vial CSL Limited, Broadmeadows, Victoria, Australia Normal Immunoglobulin (Human) Paracetamol 250 mg Tablet, soluble SmithKline Beecham (Australia) Pty Limited, Ermington, New South Wales, Australia Panadol 6 + Years Soluble Dipyridamole 200 mg Capsule, modified release Dr Karl Thomae GmbH., Biberach, Biberach an der Riss, Germany Persantin P L 200 Perlongets Goserelin acetate equivalent to 10.8 mg goserelin Implant Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zoladex 10.8 Dated this 9th day of September 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.
Publication Date
12 Sep 1996

Notice Number

1996-go5874

Page Number

2930